Fog­Phar­ma re­brands as Para­bilis Med­i­cines, as CEO Math­ai Mam­men high­lights next drugs

Fog­Phar­ma is re­nam­ing it­self as Para­bilis Med­i­cines, an­nounc­ing a new cor­po­rate iden­ti­ty Mon­day that re­flects the im­print left by CEO Math­ai Mam­men since join­ing in …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER